BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19607680)

  • 1. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study.
    Toms TE; Panoulas VF; John H; Douglas KM; Kitas GD
    Arthritis Res Ther; 2009; 11(4):R110. PubMed ID: 19607680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases.
    Abourazzak FE; Mansouri S; Najdi A; Tahiri L; Nejjari C; Harzy T
    Clin Rheumatol; 2014 Nov; 33(11):1549-55. PubMed ID: 24647982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study.
    Dao HH; Do QT; Sakamoto J
    Arthritis Res Ther; 2010; 12(6):R218. PubMed ID: 21182767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis.
    Sahebari M; Goshayeshi L; Mirfeizi Z; Rezaieyazdi Z; Hatef MR; Ghayour-Mobarhan M; Akhlaghi S; Sahebkar A; Ferns GA
    ScientificWorldJournal; 2011 Jun; 11():1195-205. PubMed ID: 21666989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis.
    Bergstra SA; Allaart CF; van den Berg R; Chopra A; Govind N; Huizinga TWJ; Landewe RBM
    Arthritis Res Ther; 2017 Nov; 19(1):258. PubMed ID: 29166919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.
    Singh JA; Hossain A; Mudano AS; Tanjong Ghogomu E; Suarez-Almazor ME; Buchbinder R; Maxwell LJ; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012657. PubMed ID: 28481462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome in rheumatoid arthritis: case control study.
    Rostom S; Mengat M; Lahlou R; Hari A; Bahiri R; Hajjaj-Hassouni N
    BMC Musculoskelet Disord; 2013 Apr; 14():147. PubMed ID: 23621997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
    Aletaha D; Smolen JS
    Rheumatology (Oxford); 2002 Dec; 41(12):1367-74. PubMed ID: 12468815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation.
    Daoussis D; Panoulas VF; John H; Toms TE; Antonopoulos I; Treharne G; Nightingale P; Douglas KM; Kitas GD
    Clin Rheumatol; 2011 Apr; 30(4):477-84. PubMed ID: 20396921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study.
    Manara M; Arcarese L; Bianchi G; Corbelli V; Epis O; Laurenti R; Migliore A; Muratore M; Roncaglione A; Rossini M; Savo M; Sinigaglia L
    Reumatismo; 2016 Dec; 68(4):188-194. PubMed ID: 28299917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
    Hilal G; Akasbi N; Boudouaya H; Salma K; Harzy T
    Curr Rheumatol Rev; 2020; 16(4):293-297. PubMed ID: 32189595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.
    Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B
    Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting addition of disease-modifying antirheumatic drugs after initial methotrexate monotherapy in patients with rheumatoid arthritis.
    Yamaguchi T; Kohyama N; Takenaka M; Okada T; Kurihara T; Sakurai K; Miwa Y; Kogo M
    Clin Rheumatol; 2021 Jul; 40(7):2657-2663. PubMed ID: 33483918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.
    Sauer BC; Teng CC; Tang D; Leng J; Curtis JR; Mikuls TR; Harrison DJ; Cannon GW
    Arthritis Care Res (Hoboken); 2017 Mar; 69(3):313-322. PubMed ID: 27273801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
    Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
    Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome in rheumatoid arthritis patients from Northeastern Brazil: Association with disease activity.
    Gomes KWP; Luz AJP; Felipe MRB; Beltrão LA; Sampaio AXC; Rodrigues CEM
    Mod Rheumatol; 2018 Mar; 28(2):258-263. PubMed ID: 28486047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90% and new DMARD in 30% of patients.
    Sokka T; Pincus T
    J Rheumatol; 2002 Dec; 29(12):2521-4. PubMed ID: 12465145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.
    Nikolaisen C; Kvien TK; Mikkelsen K; Kaufmann C; Rødevand E; Nossent JC
    Scand J Rheumatol; 2009; 38(4):240-5. PubMed ID: 19229766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice.
    Osiri M; Deesomchok U; Tugwell P
    Clin Rheumatol; 2006 Sep; 25(5):721-7. PubMed ID: 16365685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and its effect on the outcomes of rheumatoid arthritis in a multi-ethnic cohort in Singapore.
    Hee JY; Protani MM; Koh ET; Leong KP;
    Clin Rheumatol; 2022 Mar; 41(3):649-660. PubMed ID: 34655002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.